This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Top Ranked Momentum Stocks to Buy for August 5th
by Zacks Equity Research
SIMO, ON, ARCB, and MAT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 5, 2021.
Top Ranked Income Stocks to Buy for August 5th
by Zacks Equity Research
NYCB, KW, SIMO, and FCFS made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 5, 2021
This Top Computer and Technology Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Here's How Much a $1000 Investment in Silicon Motion Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Silicon Motion (SIMO) Q2 Earnings & Revenues Top Estimates
by Zacks Equity Research
Silicon Motion (SIMO) Q2 results benefit from higher sales of SSD controllers as well as eMMC and UFS controllers.
Here's Why Silicon Motion (SIMO) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Silicon Motion (SIMO) to Post Q2 Earnings: What to Expect?
by Zacks Equity Research
Silicon Motion's (SIMO) second-quarter results are likely to benefit from continued momentum in SSD controller sales, as well as healthy sales of eMMC and UFS controllers.
SIMO vs. LSCC: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SIMO vs. LSCC: Which Stock Is the Better Value Option?
Silicon Motion (SIMO) Reports Strong Preliminary Q2 Results
by Zacks Equity Research
Silicon Motion Technology (SIMO) now expects second-quarter 2021 revenues to improve 25% quarter over quarter compared with the earlier guidance of 5-10% sequential growth.
Top Ranked Income Stocks to Buy for July 8th
by Zacks Equity Research
CIT, BBY, SIMO, and BCH made it to the Zacks Rank #1 (Strong Buy) income stocks list on July 8, 2021
Ambarella's (AMBA) CVflow Vision Processor to Power Arrival's EVs
by Zacks Equity Research
Ambarella's (AMBA) technology will help Arrival produce more affordable EVs and boost global mass adoption.
Citrix's (CTXS) Secure Access Solutions Gain Solid Traction
by Zacks Equity Research
Citrix (CTXS) is benefiting from healthy uptake of solutions like Citrix Secure Internet Access and Citrix SD-WAN driven by evolving work trends.
Pitney Bowes (PBI) Set to Utilize AmbiSort Robotic System
by Zacks Equity Research
Pitney Bowes (PBI) completes a pilot run of the AmbiSort robotic system at its Bloomington e-commerce hub
Cisco (CSCO) to Aid Rakuten to Upgrade Network Infrastructure
by Zacks Equity Research
Cisco's (CSCO) Routed Optical Networking will enable Rakuten Mobile to combine all coherent pluggable optics into a router. This will make the network more automated with improved deployment speed.
SYNNEX's (SNX) Q2 Earnings & Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
SYNNEX's (SNX) second-quarter fiscal 2021 results benefit from a steady IT spending environment on the back of rapid digital transformation.
Progress Software (PRGS) Q2 Earnings & Revenues Top Estimates
by Zacks Equity Research
Progress Software's (PRGS) second-quarter fiscal 2021 results benefit from momentum in core products like OpenEdge, MOVEit and WhatsUp Gold along with Chef.
Sabre's (SABR) Q2 Guidance Reflects Improving Travel Scenario
by Zacks Equity Research
Buoyed by the improving travel industry, Sabre (SABR) expects sequential top-line growth on the back of higher bookings, a greater number of passengers boarded and increased CRS transactions.
3D Systems (DDD) Joins CollPlant for Bioprinted Breast Tissue Matrix
by Zacks Equity Research
The collaborative efforts of 3D Systems (DDD) and CollPlant aim to eliminate the odds of adverse immune response in the human body induced by procedures using tissue derived from humans and animals.
Hewlett Packard (HPE) Scoops Up Determined AI, Boosts HPC Offerings
by Zacks Equity Research
Hewlett Packard (HPE) will integrate Determined AI with its AI and HPC offerings to help ML engineers build AI and ML models at greater scale.
Zacks.com featured highlights include: AMN Healthcare Services, American Axle & Manufacturing, Generac, Silicon Motion Technology and Target
by Zacks Equity Research
Zacks.com featured highlights include: AMN Healthcare Services, American Axle & Manufacturing, Generac, Silicon Motion Technology and Target
5 Stocks Trading Near 52-Week High That Can Jump Further
by Aniruddha Ganguly
Investors target stocks that have been on a bullish run lately. Stocks like AMN, AXL, GNRC, SIMO and TGT that are seeing price strength have a high chance of carrying the momentum forward.
FireEye (FEYE) Launches Training Course to Manage Evolving Threats
by Zacks Equity Research
FireEye's (FEYE) Mandiant On-Demand Cyber Intelligence Training secures the virtual onboarding process of new security analysts and delivers advanced training to more experienced team members.
Check Point (CHKP) Expands CloudGuard Platform With New Solution
by Zacks Equity Research
Check Point's (CHKP) CloudGuard Workload Protection solution is fully automated and provides the necessary tools for security teams to automate end-to-end security across applications.
Nutanix (NTNX) to Offer Era Integrated With HPE ProLiant Servers
by Zacks Equity Research
Nutanix's (NTNX) Era will be offered in combination with HPE ProLiant servers as a service through HPE GreenLake. The service will also offer agile, elastic and pay-per-use capabilities of the cloud.
Zscaler (ZS) Announces New Enhancements to Boost Cloud Security
by Zacks Equity Research
The Zscaler (ZS) Data Protection integrations will enable customers to enhance data protection on the Now Platform, including restricting unmanaged devices by accessing ServiceNow's platform and data.